Cancer Policy


Clinical Roundup


In The Clinic
Latest Issue
NEWS ALERTS
UPCOMING EVENTS
Jun 2026
Sep 2026
Conversations with The Cancer Letter
Contributors
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
Recent Issues
The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.






























